Article Details

Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated | FierceBiotech

Retrieved on: 2021-10-08 13:17:27

Tags for this article:

Click the tags to see associated articles and topics

Pfizer, Bayer-backed Pyxis ups IPO price as biotech's public run continues unabated | FierceBiotech. View article details on HISWAI: https://www.fiercebiotech.com/biotech/pfizer-bayer-backed-pyxis-ups-ipo-price-as-biotech-s-public-run-continues-unabated

Excerpt

Pyxis has had a great year, having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a mega $152 million B round to develop them.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up